
Overview
.
Dr. Rahimian is highly rated in 16 conditions, according to our data. His top areas of expertise are Chronic Familial Neutropenia, Agranulocytosis, Squamous Cell Lung Carcinoma, and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Awards
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
420 S 5th Ave, Bldg N, West Reading, PA 19611
824 Main St, Ste 101, Phoenixville, PA 19460
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Janet Kwiatkowski is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Kwiatkowski is highly rated in 14 conditions, according to our data. Her top areas of expertise are Hemolytic Anemia, Congenital Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.
Fox Chase Cancer Center
Daniel Geynisman is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Office
Stephan Grupp is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Grupp is highly rated in 13 conditions, according to our data. His top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Shoja S. Rahimian
How do I make an appointment with Dr. Shoja S. Rahimian?
You can book an appointment with Dr. Shoja S. Rahimian by calling their office at 484-628-0900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Shoja S. Rahimian a top-rated expert for Chronic Familial Neutropenia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shoja S. Rahimian is classified as an Advanced expert for Chronic Familial Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Shoja S. Rahimian specialize in?
While Dr. Shoja S. Rahimian is a Hematology, they have specific expertise in Chronic Familial Neutropenia, Agranulocytosis, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Shoja S. Rahimian participate in research or clinical trials?
Yes. Dr. Shoja S. Rahimian has published 8 articles and abstracts on conditions like Chronic Familial Neutropenia. You can view a list of Dr. Shoja S. Rahimian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Shoja S. Rahimian accept my insurance?
Dr. Shoja S. Rahimian accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 484-628-0900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Hepatic Porphyria (AHP)Dr. Rahimian isAdvanced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Rahimian isAdvanced. Learn about Acute Intermittent Porphyria.
- AgranulocytosisDr. Rahimian isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Chronic Familial NeutropeniaDr. Rahimian isAdvanced. Learn about Chronic Familial Neutropenia.
- EGFR Positive Lung CancerDr. Rahimian isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Rahimian isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Mountain SicknessDr. Rahimian isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Rahimian isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Rahimian isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Rahimian isExperienced. Learn about Acute Promyelocytic Leukemia.
